BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $64,502 | +3444.1% | 2,682 | +4605.3% | 0.00% | – |
Q2 2023 | $1,820 | +750.5% | 57 | +714.3% | 0.00% | – |
Q1 2023 | $214 | -96.4% | 7 | -95.3% | 0.00% | – |
Q4 2022 | $5,867 | -2.2% | 150 | +15.4% | 0.00% | – |
Q3 2022 | $6,000 | +20.0% | 130 | 0.0% | 0.00% | – |
Q2 2022 | $5,000 | -37.5% | 130 | -7.8% | 0.00% | – |
Q1 2022 | $8,000 | +33.3% | 141 | +85.5% | 0.00% | – |
Q4 2021 | $6,000 | -62.5% | 76 | -57.8% | 0.00% | -100.0% |
Q3 2021 | $16,000 | 0.0% | 180 | +40.6% | 0.00% | 0.0% |
Q2 2021 | $16,000 | – | 128 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |